RELA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.366400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.471800E-01
Normal-vs-Stage2
1.611610E-02
Normal-vs-Stage3
4.360400E-01
Normal-vs-Stage4
9.568200E-02
Stage1-vs-Stage2
2.362200E-01
Stage1-vs-Stage3
6.530400E-01
Stage1-vs-Stage4
7.487600E-02
Stage2-vs-Stage3
1.198420E-01
Stage2-vs-Stage4
2.547200E-01
Stage3-vs-Stage4
9.286500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.112200E-01
Normal-vs-AfricanAmerican
6.812000E-01
Normal-vs-Asian
6.589600E-02
Caucasian-vs-AfricanAmerican
9.498200E-01
Caucasian-vs-Asian
1.554180E-01
AfricanAmerican-vs-Asian
2.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.545770E-01
Normal-vs-Female
4.059400E-01
Male-vs-Female
6.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.544000E-01
Normal-vs-Age(41-60Yrs)
3.701000E-03
Normal-vs-Age(61-80Yrs)
7.362600E-01
Normal-vs-Age(81-100Yrs)
7.261600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.350800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.780800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.216200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.794000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.554100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.668800E-01
Normal-vs-Daily Drinker
3.960400E-01
Normal-vs-Weekly Drinker
1.726620E-01
Normal-vs-Occasional Drinker
1.032440E-01
Normal-vs-Social Drinker
6.991400E-01
Non Drinker-vs-Daily Drinker
4.053200E-01
Non Drinker-vs-Weekly Drinker
1.861200E-01
Non Drinker-vs-Occasional Drinker
1.267990E-01
Non Drinker-vs-Social Drinker
6.673000E-01
Daily Drinker-vs-Weekly Drinker
6.353200E-01
Daily Drinker-vs-Occasional Drinker
5.411600E-01
Daily Drinker-vs-Social Drinker
7.532600E-01
Weekly Drinker-vs-Occasional Drinker
9.205800E-01
Weekly Drinker-vs-Social Drinker
4.321000E-01
Occasional Drinker-vs-Social Drinker
3.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.438000E-01
Normal-vs-Grade 2
7.018800E-01
Normal-vs-Grade 3
6.668800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.956920E-04
Grade 1-vs-Grade 3
4.157100E-04
Grade 1-vs-Grade 4
9.438000E-01
Grade 2-vs-Grade 3
4.343200E-01
Grade 2-vs-Grade 4
7.018800E-01
Grade 3-vs-Grade 4
6.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.289800E-01
Normal-vs-NonDiabetic
5.325800E-02
Diabetic-vs-NonDiabetic
6.221800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.763600E-03
Normal-vs-NoPancreatitis
2.746000E-01
Pancreatitis-vs-NoPancreatitis
2.193800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.217000E-01
Normal-vs-N1
6.106200E-02
N0-vs-N1
3.926200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.189100E-04
Normal-vs-TP53-NonMutant
5.639700E-02
TP53-Mutant-vs-TP53-NonMutant
1.35840000003995E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
